New discovery a step towards better diabetes treatment

Jul 01, 2008

In today's issue of the prestigious journal Cell Metabolism Uppsala scientists are presenting new findings that shed light on the processes that determine the release of the blood sugar-lowering hormone insulin. The discovery is based on the development of image analysis methods that make possible the detailed study of events immediately inside the plasma membrane of the insulin-secreting cells.

Cyclic AMP (cAMP) is a universal messenger molecule that controls a number of different
functions inside the cell. For example, it plays a role in the release of insulin from the beta
cells in the pancreas (see Facts). It is well-known that the production of cAMP explains how certain hormones can amplify insulin secretion. On the other hand, it has been unclear to what extent cAMP also contributes to the major release of insulin triggered by an increase in blood sugar (glucose).

Anders Tengholms research team at Uppsala University has developed methods that make it
possible for the first time to measure both the secretion of insulin and the cAMP concentration
in individual beta cells. The results show that ATP, the energy-rich molecule that is produced
when glucose is metabolized, causes an increase in cAMP concentration right at the cell
membrane where the release of insulin takes place. This increase varies rhythmically and
coincides with similarly regular variations in another stimulant messenger, the calcium ion,
resulting in pulsatile secretion of insulin.

Optimal glucose-induced insulin secretion requires that the varying cAMP
and calcium signals are coordinated in time. The study sheds new light on the cellular
mechanisms that underlie the pulsatile release of insulin in healthy individuals, says Anders Tengholm.

The discovery that the cell metabolism directly stimulates the production of cAMP
illustrates a new principle for the regulation of this messenger molecule. The connection between metabolism and cAMP is not only important for the secretion of insulin; it also
plays a role in gene regulation, cell growth, and cell survival. The observations thereby pave the way for understanding of the disturbed beta cell function in type 2 diabetes and for the
development of new drugs for the disease.

Source: Uppsala University

Explore further: Recorded Ebola deaths top 7,000

add to favorites email to friend print save as pdf

Related Stories

Dynamics of crucial protein 'switch' revealed

May 17, 2011

Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological ...

New discovery may unlock human genome

Dec 29, 2004

Goodman laboratory devises technique to explain patterns of gene regulation An Oregon Health & Science University-led development of a technique for identifying control elements that drive the expression of genes in brain cel ...

Recommended for you

Recorded Ebola deaths top 7,000

18 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

22 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.